GENERICS AND BIOSIMILARS INITIATIVE JOURNAL
Official Journal of the Generics and Biosimilars Initiative
Volume 14 / Year 2025 / Issue 3
Editorial
Biosimilars in oncology: beyond regulation—building confidence through evidence and dialogue
Author(s): Professor César Humberto Oyarzo Mansilla, MEcon
Page: 73Abstract: This editorial discusses systemic barriers limiting oncology biosimilar adoption in Chile and Latin America, emphasizing trust, education, and coordinated policy actions to strengthen value, equity, and confidence in biosimilars. The manuscript by Paredes-Fernández and Lenz-Alcayaga [1] addresses a key but often neglected question in Latin America: why have biosimilars, despite their proven safety, efficacy, […]
Rising costs of biologicals: effective cost-containment does not please all stakeholders
Author(s): Adjunct Professor Pekka Kurki, MD, PhD
Page: 74Abstract: Rieger and Holland provided a report of a stakeholder meeting dealing with the biosimilar uptake in Australia. The proposed policy measures reported may not have a dramatic effect on the biosimilar uptake. From the scientific and medical point of view, the biotech industry has developed wonderful medicines for treating chronic and life-threatening diseases. Unfortunately, […]
